Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 May;91(1):171–177. doi: 10.1111/j.1476-5381.1987.tb08996.x

Influence of alpha-chymotrypsin and trypsin on the non-adrenergic non-cholinergic relaxation in the rat gastric fundus.

F A De Beurme, R A Lefebvre
PMCID: PMC1853483  PMID: 3594075

Abstract

Relaxations of the rat gastric fundus were induced by electrical stimulation of the non-adrenergic non-cholinergic (NANC) neurones, by vasoactive intestinal polypeptide (VIP), by noradrenaline and by isopropylnoradrenaline. The influence of alpha-chymotrypsin and trypsin thereupon was studied. alpha-Chymotrypsin 2 u ml-1, present for 30 min, antagonized completely the VIP-induced relaxation, but not the stimulation-induced relaxation; alpha-chymotrypsin 10 u ml-1 also partially antagonized the stimulation-induced relaxation. When alpha-chymotrypsin 2 u ml-1 was added after the relaxation had occurred, it antagonized completely the VIP-induced relaxation, but it also partially antagonized the stimulation-induced relaxation. The partial antagonism of the stimulation-induced relaxation was more pronounced with alpha-chymotrypsin 10 u ml-1. Trypsin, 10(-6) M and 3 X 10(-6) M, had effects on VIP- and stimulation-induced relaxations similar to those of alpha-chymotrypsin. The relaxations induced by noradrenaline and isopropylnoradrenaline were not influenced by alpha-chymotrypsin or trypsin, respectively. The results suggest that a peptide, possibly VIP, is involved in the NANC relaxation of the rat gastric fundus.

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altiere R. J., Diamond L. Effect of alpha-chymotrypsin on the nonadrenergic noncholinergic inhibitory system in cat airways. Eur J Pharmacol. 1985 Aug 7;114(1):75–78. doi: 10.1016/0014-2999(85)90523-0. [DOI] [PubMed] [Google Scholar]
  2. Angel F., Go V. L., Schmalz P. F., Szurszewski J. H. Vasoactive intestinal polypeptide: a putative transmitter in the canine gastric muscularis mucosa. J Physiol. 1983 Aug;341:641–654. doi: 10.1113/jphysiol.1983.sp014830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gilfoil T. M., Kelly C. A. Mechanism of action of chymotrypsin on plain muscle. Br J Pharmacol Chemother. 1966 May;27(1):120–130. doi: 10.1111/j.1476-5381.1966.tb01647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hills J., Meldrum L. A., Klarskov P., Burnstock G. A novel non-adrenergic, non-cholinergic nerve-mediated relaxation of the pig bladder neck: an examination of possible neurotransmitter candidates. Eur J Pharmacol. 1984 Apr 6;99(4):287–293. doi: 10.1016/0014-2999(84)90135-3. [DOI] [PubMed] [Google Scholar]
  5. Laburthe M., Couvineau A., Rouyer-Fessard C. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat. Mol Pharmacol. 1986 Jan;29(1):23–27. [PubMed] [Google Scholar]
  6. Lefebvre R. A. Study on the possible neurotransmitter of the non-adrenergic non-cholinergic innervation of the rat gastric fundus. Arch Int Pharmacodyn Ther. 1986 Apr;280(2 Suppl):110–136. [PubMed] [Google Scholar]
  7. Lefebvre R. A., Verplanken P. A., Bogaert M. G. Pharmacological characterization of the postjunctional beta-adrenoceptors in the rat gastric fundus. Eur J Pharmacol. 1984 Oct 30;106(1):1–9. doi: 10.1016/0014-2999(84)90671-x. [DOI] [PubMed] [Google Scholar]
  8. Mackenzie I., Burnstock G. Evidence against vasoactive intestinal polypeptide being the non-adrenergic, non-cholinergic inhibitory transmitter released from nerves supplying the smooth muscle of the guinea-pig taenia coli. Eur J Pharmacol. 1980 Oct 17;67(2-3):255–264. doi: 10.1016/0014-2999(80)90506-3. [DOI] [PubMed] [Google Scholar]
  9. Manzini S., Maggi C. A., Meli A. Further evidence for involvement of adenosine-5'-triphosphate in non-adrenergic non-cholinergic relaxation of the isolated rat duodenum. Eur J Pharmacol. 1985 Jul 31;113(3):399–408. doi: 10.1016/0014-2999(85)90088-3. [DOI] [PubMed] [Google Scholar]
  10. Manzini S., Maggi C. A., Meli A. Pharmacological evidence that at least two different non-adrenergic non-cholinergic inhibitory systems are present in the rat small intestine. Eur J Pharmacol. 1986 Apr 16;123(2):229–236. doi: 10.1016/0014-2999(86)90664-3. [DOI] [PubMed] [Google Scholar]
  11. Pandol S. J., Dharmsathaphorn K., Schoeffield M. S., Vale W., Rivier J. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP. Am J Physiol. 1986 Apr;250(4 Pt 1):G553–G557. doi: 10.1152/ajpgi.1986.250.4.G553. [DOI] [PubMed] [Google Scholar]
  12. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Verplanken P. A., Lefebvre R. A., Bogaert M. G. Pharmacological characterization of alpha adrenoceptors in the rat gastric fundus. J Pharmacol Exp Ther. 1984 Nov;231(2):404–410. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES